SCHEMBL3267463

SCHEMBL3267463

O=Cc1ccc(NS(=O)(=O)c2ccc(Cl)cc2Cl)cc1

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC1 Q13547 2/20 0.66
HDAC8 Q9BY41 1/20 0.66
MAPT P10636 3/20 0.60
LMNA P02545 2/20 0.60
MEN1 O00255 1/20 0.60
ALOX12 P18054 1/20 0.60
KMT2A Q03164 1/20 0.60
NLRP1 Q9C000 1/20 0.60
ITGA1 P56199 4/20 0.59
PPARG P37231 6/20 0.54
ALDH1A1 P00352 2/20 0.49
HTT P42858 2/20 0.49
MAPK1 P28482 1/20 0.49
CYP3A4 P08684 1/20 0.47
CDK1 P06493 1/20 0.47
CCNB1 P14635 1/20 0.47
CCNA2 P20248 1/20 0.47
CDK2 P24941 1/20 0.47
CDK7 P50613 1/20 0.47
CCNH P51946 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL94831 0.81 MAPT (0.63) HDAC1HDAC8MAPTLMNAMEN1
SCHEMBL28121241 0.81 MAPT (0.63) HDAC1HDAC8MAPTLMNAMEN1
SCHEMBL14018772 0.81 MAPT (0.63) HDAC1HDAC8MAPTLMNAMEN1
SCHEMBL7577795 0.81 ITGA1 (0.74) HDAC1HDAC8MAPTLMNAMEN1
SCHEMBL5020767 0.80 HDAC1 (0.78) HDAC1HDAC8MAPTLMNAMEN1
SCHEMBL5020625 0.80 HDAC1 (1.00) HDAC1HDAC8MAPTLMNAMEN1
SCHEMBL3268657 0.80 MAPT (0.61) HDAC1HDAC8MAPTLMNAMEN1
SCHEMBL3267775 0.79 PPARG (0.52) HDAC1HDAC8MAPTLMNAMEN1
SCHEMBL4882914 0.79 PGR (0.61) HDAC1HDAC8MAPTLMNAMEN1
SCHEMBL3267231 0.78 ITGA1 (0.61) HDAC1HDAC8MAPTLMNAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1914229-B1 NOVEL CERCOSPORAMIDE DERIVATIVE DAIICHI SANKYO CO LTD (JP) 2010-06-16 EP disclosed
US-20090036492-A1 Novel Cercosporamide Derivative DAIICHI SANKYO COMPANY, LIMITED (JP) 2009-02-05 US disclosed
EP-1914229-A1 NOVEL CERCOSPORAMIDE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2008-04-23 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090036492-A1 Novel Cercosporamide Derivative GPR119, CBR3, SLC5A2 HDAC1 765/4885HDAC8 1099/4885MAPT 4836/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.